chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation, Stomatitis, Throat irritation, Throat tightness, Vaccination site reaction
Clinical narrative: Face was pretty red; throat started to tighten; (throat) feeling really scratchy; started to lose voice; inside of my mouth and my lips started getting tangly; (inside of my mouth and my lips) prickly, (inside of my mouth and my lips) non-feeling; vaccination reaction; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Face was pretty red), THROAT TIGHTNESS (throat started to tighten), THROAT IRRITATION ((throat) feeling really scratchy), DYSPHONIA (started to lose voice) and STOMATITIS (inside of my mouth and my lips started getting tangly) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy and Allergy (allergic to preservatives).    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced ERYTHEMA (Face was pretty red), THROAT TIGHTNESS (throat started to tighten), THROAT IRRITATION ((throat) feeling really scratchy), DYSPHONIA (started to lose voice), STOMATITIS (inside of my mouth and my lips started getting tangly), HYPOAESTHESIA ORAL ((inside of my mouth and my lips) prickly, (inside of my mouth and my lips) non-feeling) and VACCINATION SITE REACTION (vaccination reaction). The patient was treated with EPINEPHRINE at a dose of half dose. At the time of the report, ERYTHEMA (Face was pretty red), THROAT TIGHTNESS (throat started to tighten), THROAT IRRITATION ((throat) feeling really scratchy), DYSPHONIA (started to lose voice), STOMATITIS (inside of my mouth and my lips started getting tangly), HYPOAESTHESIA ORAL ((inside of my mouth and my lips) prickly, (inside of my mouth and my lips) non-feeling) and VACCINATION SITE REACTION (vaccination reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: normal. On an unknown date, Full blood count: normal. On an unknown date, Oxygen saturation: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Doctor recommends not to get the second dose and to contact primary doctor and go to an allergist specialist.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Non-significant Follow up- Contact information updated
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site mass, Muscular weakness, Nausea, Pain
Clinical narrative: Naseated; Hardness was the size of a palm; Was Tingling; Little bump on arm; Itchy; Slight headache; Throbbing; Arm felt weaker; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Was Tingling), INJECTION SITE MASS (Little bump on arm), VACCINATION SITE INDURATION (Hardness was the size of a palm), PRURITUS (Itchy) and HEADACHE (Slight headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concomitant products included BIOTIN, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and MAGNESIUM OXIDE HEAVY, SODIUM BICARBONATE (ANTACID C) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Was Tingling), INJECTION SITE MASS (Little bump on arm), VACCINATION SITE INDURATION (Hardness was the size of a palm), PRURITUS (Itchy), HEADACHE (Slight headache), PAIN (Throbbing), NAUSEA (Naseated) and MUSCULAR WEAKNESS (Arm felt weaker). At the time of the report, PARAESTHESIA (Was Tingling), INJECTION SITE MASS (Little bump on arm), VACCINATION SITE INDURATION (Hardness was the size of a palm), PRURITUS (Itchy), HEADACHE (Slight headache), PAIN (Throbbing), NAUSEA (Naseated) and MUSCULAR WEAKNESS (Arm felt weaker) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus, Vaccination site induration
Clinical narrative: Naseated; Hardness was the size of a palm; Was Tingling; Little bump on arm; Itchy; Slight headache; Throbbing; Arm felt weaker; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Was Tingling), INJECTION SITE MASS (Little bump on arm), VACCINATION SITE INDURATION (Hardness was the size of a palm), PRURITUS (Itchy) and HEADACHE (Slight headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concomitant products included BIOTIN, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and MAGNESIUM OXIDE HEAVY, SODIUM BICARBONATE (ANTACID C) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Was Tingling), INJECTION SITE MASS (Little bump on arm), VACCINATION SITE INDURATION (Hardness was the size of a palm), PRURITUS (Itchy), HEADACHE (Slight headache), PAIN (Throbbing), NAUSEA (Naseated) and MUSCULAR WEAKNESS (Arm felt weaker). At the time of the report, PARAESTHESIA (Was Tingling), INJECTION SITE MASS (Little bump on arm), VACCINATION SITE INDURATION (Hardness was the size of a palm), PRURITUS (Itchy), HEADACHE (Slight headache), PAIN (Throbbing), NAUSEA (Naseated) and MUSCULAR WEAKNESS (Arm felt weaker) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pain, Pruritus, Urticaria
Clinical narrative: Heat; Itchiness; Pain; broke out in hives/irst noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs; A spontaneous report was received from a consumer of 38 years old female patient who experienced broke out in hives/first noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs, heat, itchiness and pain.   The patient's medical history was not provided.    Concomitant medications included Synthroid (levothyroxine sodium) at 100 milligram  once daily via unknown route for an unknown indication.   On 06-Feb-2021, prior to the onset of the events  the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) intramuscularly in the unknown anatomical location for prophylaxis of COVID-19 infection.   On 12-Feb-2021, the patient experienced broke out in hives/first noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs, and on 13-Feb-2021 experienced pain, heat, itchiness and pain.    Treatment information included Benadryl at an unknown dose and frequency via an unknown route for the events broke out in hives/first noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs, heat, itchiness and pain.   Action taken with mRNA-1273 in response to the events broke out in hives/first noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs, heat, itchiness and pain was unknown at the time of reporting.  The outcome of the events broke out in hives/first noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs was recovered on an unknown date and the outcome of the events heat, itchiness and pain was unknown at the time of reporting.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chest discomfort, Cough, Dysphonia, Fatigue
Clinical narrative: Extreme fatigue/ very tired; Upset stomach; hoarseness; Dry cough; Muscle aches; Tightness in chest; Headache that comes and goes; Feel lousy; A spontaneous report was received from a consumer, concerning  a 76 years adult male patient, who received Moderna COVID-19 Vaccine and experienced 1 dose.  The patient's medical history was not provided.  The concomitant products was not provided.  On  09-Feb-2021,prior to the onset of events,the patient received the first dose of  mRNA-1273(lot number: 031M20A) and route of administration is  intramuscular route for COVID-19 infection prophylaxis.   Patient got vaccine on 9 feb21. Caller said she has Extreme fatigue, Upset stomach, anxiety.  Caller wanted to know, Are these symptoms normal. Symptoms are lingering. She said everyday she wakes up she feel lousy. she has mild symptoms. Every day she has hoarseness, dry cough, muscle aches and is Very tired. She has tightness in chest. She had her first dose 9feb21. She said she had COVID in September and that she had antibodies after the virus. She also had headache that comes and goes. Her concern, about second dose. She has asthma in the past.  Treatment history was not provided.  Action taken with mRNA-1273 in response to the events were not reported.  The Outcome of the event(s)  was considered to be not resolved at the time of this report.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Myalgia
Clinical narrative: Extreme fatigue/ very tired; Upset stomach; hoarseness; Dry cough; Muscle aches; Tightness in chest; Headache that comes and goes; Feel lousy; A spontaneous report was received from a consumer, concerning  a 76 years adult male patient, who received Moderna COVID-19 Vaccine and experienced 1 dose.  The patient's medical history was not provided.  The concomitant products was not provided.  On  09-Feb-2021,prior to the onset of events,the patient received the first dose of  mRNA-1273(lot number: 031M20A) and route of administration is  intramuscular route for COVID-19 infection prophylaxis.   Patient got vaccine on 9 feb21. Caller said she has Extreme fatigue, Upset stomach, anxiety.  Caller wanted to know, Are these symptoms normal. Symptoms are lingering. She said everyday she wakes up she feel lousy. she has mild symptoms. Every day she has hoarseness, dry cough, muscle aches and is Very tired. She has tightness in chest. She had her first dose 9feb21. She said she had COVID in September and that she had antibodies after the virus. She also had headache that comes and goes. Her concern, about second dose. She has asthma in the past.  Treatment history was not provided.  Action taken with mRNA-1273 in response to the events were not reported.  The Outcome of the event(s)  was considered to be not resolved at the time of this report.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Arm is red at injection site; Arm swollen at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Arm is red at injection site) and VACCINATION SITE SWELLING (Arm swollen at injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Arm is red at injection site) and VACCINATION SITE SWELLING (Arm swollen at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (Arm is red at injection site) and VACCINATION SITE SWELLING (Arm swollen at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Follow up received contains no new information.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Chills; Fever; Fatigue; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever), FATIGUE (Fatigue) and PAIN (Soreness) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included HYDROCHLOROTHIAZIDE for Diuretic therapy, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and LOVASTATIN for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever), FATIGUE (Fatigue) and PAIN (Soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), PYREXIA (Fever), FATIGUE (Fatigue) and PAIN (Soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache unrelated to Moderna's vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache unrelated to Moderna's vaccine) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy and Sinusitis.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced HEADACHE (Headache unrelated to Moderna's vaccine). At the time of the report, HEADACHE (Headache unrelated to Moderna's vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Skin reaction
Clinical narrative: Topical reaction from the first COVID vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SKIN REACTION (Topical reaction from the first COVID vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN REACTION (Topical reaction from the first COVID vaccine). At the time of the report, SKIN REACTION (Topical reaction from the first COVID vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Sinus headache
Clinical narrative: sinus headache; cold; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SINUS HEADACHE (sinus headache) and NASOPHARYNGITIS (cold) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced SINUS HEADACHE (sinus headache) and NASOPHARYNGITIS (cold). At the time of the report, SINUS HEADACHE (sinus headache) and NASOPHARYNGITIS (cold) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information for the events was provided by the reporter as Azithromycin 500mg for ten days. No concomitant medications were provided by reporter.   Reporter did not allow further contact
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site erythema
Clinical narrative: redness from the injection site to the inside of the elbow; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness from the injection site to the inside of the elbow) and NAUSEA (nausea) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced NAUSEA (nausea). On 18-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness from the injection site to the inside of the elbow). At the time of the report, VACCINATION SITE ERYTHEMA (redness from the injection site to the inside of the elbow) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided by reporter.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Vaccination site pain
Clinical narrative: Numbness on the entire shot arm, nose, face, side of face; injection site soreness; tingly on the entire shot arm, nose, face, side of face; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness on the entire shot arm, nose, face, side of face), VACCINATION SITE PAIN (injection site soreness) and PARAESTHESIA (tingly on the entire shot arm, nose, face, side of face) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced PARAESTHESIA (tingly on the entire shot arm, nose, face, side of face). On 25-Jan-2021, the patient experienced HYPOAESTHESIA (Numbness on the entire shot arm, nose, face, side of face) and VACCINATION SITE PAIN (injection site soreness). At the time of the report, HYPOAESTHESIA (Numbness on the entire shot arm, nose, face, side of face) and PARAESTHESIA (tingly on the entire shot arm, nose, face, side of face) had resolved and VACCINATION SITE PAIN (injection site soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia
Clinical narrative: fever; Chills; Nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PYREXIA (fever) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-020771.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Diagnosed with COVID-19 after first shot; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with COVID-19 after first shot) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced COVID-19 (Diagnosed with COVID-19 after first shot). On 17-Jan-2021, COVID-19 (Diagnosed with COVID-19 after first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pruritus, Skin discolouration, Vaccination site erythema
Clinical narrative: Itching and feels heavy; changed to a reddish-brown color; swollen glands under arm; red and as big as her hand on arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching and feels heavy), SKIN DISCOLOURATION (changed to a reddish-brown color), LYMPHADENOPATHY (swollen glands under arm) and VACCINATION SITE ERYTHEMA (red and as big as her hand on arm) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching and feels heavy), SKIN DISCOLOURATION (changed to a reddish-brown color), LYMPHADENOPATHY (swollen glands under arm) and VACCINATION SITE ERYTHEMA (red and as big as her hand on arm). The patient was treated with IBUPROFEN (ADVIL 12HOUR) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching and feels heavy), SKIN DISCOLOURATION (changed to a reddish-brown color), LYMPHADENOPATHY (swollen glands under arm) and VACCINATION SITE ERYTHEMA (red and as big as her hand on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       patient also used cold packs as treatment.
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Faeces discoloured
Clinical narrative: Three or four days later diarrhea started; Colour is blackish (possibly blood); A spontaneous report was received from a consumer concerning herself, a 96-year-old patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced diarrhea three or four days later and the color was blackish (possibly blood) / faeces discoloration.  The patient's medical history was not provided. Concomitant product use was not provided.  On 27 Jan 2021, approximately three days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: 043L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 30 Jan 2021, the patient experienced diarrhea and the color was blackish (possibly blood). The patient reports that the diarrhea has continued and she was concerned about the second dose of vaccine that was scheduled on 24 Feb 2021.  Treatment information, included that the patient have not taken any medications.  Action taken with mRNA-1273 in response to the events was not reported.   The event, diarrhea was not resolved at the time of report and the outcome of the event, color was blackish (possibly blood) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site warmth, Pain in extremity, Vaccination site erythema
Clinical narrative: Red bullseye around injection site; Arm started to feel hot and feverish; Incredibly itchy; Sore arm shoulder to elbow; A spontaneous report was received from a consumer concerning a 75 year old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection site pruritus/extremely itching, sore arm shoulder to arm/ Pain in arm, injection site warm/hot and feverish  The patient's medical history was not provided by the reporter. Concomitant product use was not reported.   On 13 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011M20A) for prophylaxis of COVID-19 infection. After receiving the mRNA-1273 vaccine, patient injection site pruritus/extremely itching, sore arm shoulder to arm/ Pain in arm, injection site warm/hot and feverish.  Treatment details for events was anti-itch spray but it didn't work.   Action taken with mRNA-1273 in response to the events was not reported.   The  outcome of the events, sore arm shoulder to arm/ Pain in arm, injection site warm/hot and feverish were considered to be unknown at the time of this report. The outcome the event, injection site pruritus/extremely itching  was considered to be recovered/resolved.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Insomnia
Clinical narrative: Abdominal cramps; night time awaking, can't sleep; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Abdominal cramps) and INSOMNIA (night time awaking, can't sleep) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced ABDOMINAL PAIN (Abdominal cramps) and INSOMNIA (night time awaking, can't sleep). At the time of the report, ABDOMINAL PAIN (Abdominal cramps) and INSOMNIA (night time awaking, can't sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia
Clinical narrative: High fever; Chills; Nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PYREXIA (High fever), CHILLS (Chills) and NAUSEA (Nausea) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PYREXIA (High fever), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, PYREXIA (High fever), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.            This case was linked to MOD-2021-020745 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Myalgia, Vomiting
Clinical narrative: Abdominal pain; Feeling sore; Vomited three time Thursday and Friday; A Spontaneous case was received from consumer , concerning a male patient  of age 30, who received Moderna's COVID-19 vaccine experienced Myalgia/ Feeling sore, Vomiting/ Vomited three time Thursday and Friday , Abdominal pain.  The patient's medical history was not provided. The Patient's concomitant medications was not provided.  On  17Feb2021 , prior to the onset of events, the patient received her first of two planned doses of mRNA-1273 (Batch number : unknown) via unspecified route for COVID-19 infection prophylaxis.  On 18Feb2021, the patient woke up feeling sore, he vomited three times on Thursday, and Friday, he is complaining of abdominal pain.  The action taken in response to the events, Myalgia, Vomiting, Abdominal pain was unknown.  The outcome of the events, Myalgia, Vomiting, Abdominal pain was considered to be unknown.  The treatment medications reported to be taken by the patient were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus
Clinical narrative: itching over arm and face; hot over arm and face; red over arm and face; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching over arm and face), FEELING HOT (hot over arm and face) and ERYTHEMA (red over arm and face) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PRURITUS (itching over arm and face), FEELING HOT (hot over arm and face) and ERYTHEMA (red over arm and face). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PRURITUS (itching over arm and face), FEELING HOT (hot over arm and face) and ERYTHEMA (red over arm and face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jan-2021: Upon internal review on 07 Jun 2021, it was discovered that the patient age was incorrectly captured as 121 years and DOB mentioned in source document was 01-Jan-1900, which was a MI error. The patient age and narrative has been updated to unknown age with reports re-submission and significant amendment is performed for the correction.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: warm touch around the site of injection; Itchy around the site of injection; Knot around the site of injection; Red around the site of injection; Sore around the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm touch around the site of injection), VACCINATION SITE PRURITUS (Itchy around the site of injection), VACCINATION SITE INDURATION (Knot around the site of injection), VACCINATION SITE ERYTHEMA (Red around the site of injection) and VACCINATION SITE PAIN (Sore around the site of injection) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm touch around the site of injection), VACCINATION SITE PRURITUS (Itchy around the site of injection), VACCINATION SITE INDURATION (Knot around the site of injection), VACCINATION SITE ERYTHEMA (Red around the site of injection) and VACCINATION SITE PAIN (Sore around the site of injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (warm touch around the site of injection), VACCINATION SITE PRURITUS (Itchy around the site of injection), VACCINATION SITE INDURATION (Knot around the site of injection), VACCINATION SITE ERYTHEMA (Red around the site of injection) and VACCINATION SITE PAIN (Sore around the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Influenza like illness
Clinical narrative: Tested positive for COVID-19; Flu like symptoms; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and COVID-19 (Tested positive for COVID-19) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 02-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and COVID-19 (Tested positive for COVID-19) outcome was unknown.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Injection site pain
Clinical narrative: Trouble walking; Joint Pain in his right knee; Mild soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Trouble walking), ARTHRALGIA (Joint Pain in his right knee) and INJECTION SITE PAIN (Mild soreness at the injection site) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included Knee injury (Injury to right knee from Football about 60yrs ago.).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced GAIT DISTURBANCE (Trouble walking), ARTHRALGIA (Joint Pain in his right knee) and INJECTION SITE PAIN (Mild soreness at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (Trouble walking), ARTHRALGIA (Joint Pain in his right knee) and INJECTION SITE PAIN (Mild soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Small Red Area on arm just below injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Small Red Area on arm just below injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Small Red Area on arm just below injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Small Red Area on arm just below injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pyrexia
Clinical narrative: high fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high fever) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in January 2021.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced PYREXIA (high fever). On 29-Jan-2021, PYREXIA (high fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, COVID-19: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Hepatic enzyme increased
Clinical narrative: liver enzymes were higher than usual; This spontaneous case was reported by a consumer and describes the occurrence of HEPATIC ENZYME INCREASED (liver enzymes were higher than usual) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced HEPATIC ENZYME INCREASED (liver enzymes were higher than usual). At the time of the report, HEPATIC ENZYME INCREASED (liver enzymes were higher than usual) outcome was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: has been running a fever; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore) and PYREXIA (has been running a fever) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). On an unknown date, the patient experienced PYREXIA (has been running a fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm was sore) and PYREXIA (has been running a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Injection site swollen and red; injection site started to itch; Injection site swollen and red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site started to itch), VACCINATION SITE ERYTHEMA (Injection site swollen and red) and VACCINATION SITE SWELLING (Injection site swollen and red) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection site started to itch) and VACCINATION SITE ERYTHEMA (Injection site swollen and red). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Injection site swollen and red). At the time of the report, VACCINATION SITE PRURITUS (injection site started to itch), VACCINATION SITE ERYTHEMA (Injection site swollen and red) and VACCINATION SITE SWELLING (Injection site swollen and red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site reaction
Clinical narrative: Itching Injection Site; Roughness in the skin of the Injection Site about 2" inches.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching Injection Site) and VACCINATION SITE REACTION (Roughness in the skin of the Injection Site about 2" inches.) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching Injection Site) and VACCINATION SITE REACTION (Roughness in the skin of the Injection Site about 2" inches.). At the time of the report, VACCINATION SITE PRURITUS (Itching Injection Site) and VACCINATION SITE REACTION (Roughness in the skin of the Injection Site about 2" inches.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pain in extremity, Pregnancy test, Ultrasound foetal
Clinical narrative: received vaccine while pregnant; sore arm; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (received vaccine while pregnant) and PAIN IN EXTREMITY (sore arm) in a 35-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]), FISH OIL and COLECALCIFEROL (VIT D [COLECALCIFEROL]) for an unknown indication.    On 11-Feb-2021 at 5:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in August 2020 and the estimated date of delivery was 04-Jun-2021. On 11-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (received vaccine while pregnant) and PAIN IN EXTREMITY (sore arm). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 11-Feb-2021, EXPOSURE DURING PREGNANCY (received vaccine while pregnant) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2020, Ultrasound foetal: normal (normal) Good. On 24-Sep-2020, Pregnancy test: positive (Positive) Positive. On 23-Oct-2020, Ultrasound foetal: normal (normal) Good.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient previously had live birth on 16-JUL-2016  On 24-SEP-2020, the patient had positive pregnancy test. The estimated date of conception was SEP-2020. No treatment information was provided.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Nausea, Pain
Clinical narrative: Dizziness; Body pain; Nausea; Headache; Tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN (Body pain), HEADACHE (Headache), FATIGUE (Tired) and NAUSEA (Nausea) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Depression. Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR) and LISINOPRIL for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced HEADACHE (Headache) and FATIGUE (Tired). On 22-Feb-2021, the patient experienced DIZZINESS (Dizziness), PAIN (Body pain) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), PAIN (Body pain), HEADACHE (Headache), FATIGUE (Tired) and NAUSEA (Nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: allergic reaction after the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction after the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction after the vaccine). At the time of the report, HYPERSENSITIVITY (allergic reaction after the vaccine) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pyrexia
Clinical narrative: Low grade fever; Profound myalgia; Fatigue; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PYREXIA (Low grade fever), MYALGIA (Profound myalgia) and FATIGUE (Fatigue) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021 at 4:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021 at 4:00 AM, the patient experienced PYREXIA (Low grade fever).   On 23-Jan-2021 at 4:00 AM, the patient experienced MYALGIA (Profound myalgia) and FATIGUE (Fatigue). On 24-Jan-2021 at 4:00 AM, PYREXIA (Low grade fever), MYALGIA (Profound myalgia) and FATIGUE (Fatigue) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Blister, Pruritus
Clinical narrative: Itchy blister spots; Itchy blister spots; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy blister spots) and BLISTER (Itchy blister spots) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   On 16-Feb-2021, the patient experienced PRURITUS (Itchy blister spots) and BLISTER (Itchy blister spots). At the time of the report, PRURITUS (Itchy blister spots) and BLISTER (Itchy blister spots) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Hyperhidrosis
Clinical narrative: Sweating; Anxiety in her chest; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating) and ANXIETY (Anxiety in her chest) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 16-Jan-2021, the patient experienced HYPERHIDROSIS (Sweating) and ANXIETY (Anxiety in her chest).   At the time of the report, HYPERHIDROSIS (Sweating) and ANXIETY (Anxiety in her chest) outcome was unknown. Not provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.